Received Aug 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | 946904 | IM / RA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z002520 | SC / RA |
| SMALLMNK | SMALLPOX + MONKEYPOX (JYNNEOS) | BAVARIAN NORDIC | UNK | 96868 | SC / LA |
Patient was administered 3 vaccines that were ordered for another patient on 8/5/2025 around 9am. Provider was notified of patient receiving vaccines and discussion whether there were any risk involved. Provider assure that vaccines were appropriate and would not cause any harm to patient. Patient was contacted and informed of error and giving information of assurance that no harm was indicated in event of vaccines received. Patient humbly verbalized understanding. Vaccines Heplisav-B, Mpox and MMRII was document and noted event in patient chart.
lipitor,biktarvy, zyrtec, vitamin D3, lisinopril, prilosec and zoloft
No known drug allergies
none warrant